Why the study?
Previous ACOG guidelines on hormonal contraception in women with pre-existing conditions were out of date, and CDC point-form guidelines lacked context for clinical rationale.
Population
Women with non-cardiovascular coexisting medical conditions seeking contraception
Design
Comprehensive review
Key result
Hormonal contraception guidelines for women with non-cardiovascular comorbidities are updated to address lower dose pills and the increased incidence of conditions like metabolic syndrome.
Authors
Loading...
Adopt CDC US MEC for contraceptive decisions in women with comorbidities; extends outdated ACOG bulletin with current point-form guidance.
This review provides updated evidence on the use of hormonal contraception in women with non-cardiovascular comorbidities to supplement existing CDC guidelines.
Feinberg et al. (2020) conducted a review in Non-cardiovascular coexisting medical conditions. Hormonal contraception was evaluated. Hormonal contraception guidelines for women with non-cardiovascular comorbidities are updated to address lower dose pills and the increased incidence of conditions like metabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: